Plexus Corp. (PLXS) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call shows a mixed picture. While there is confidence in growth, particularly in the Healthcare and Defense sectors, there are concerns over flat revenue in key areas like Industrial and Aerospace. The Q&A reveals uncertainty in the aerospace sector and reliance on future program ramps. Despite positive guidance and strategic investments, the flat revenue and minor delays temper expectations, leading to a neutral outlook.
Key Financial Performance
Revenue $1.058 billion, marking the third consecutive quarter of sequential growth. This was driven by late-quarter demand upside from semi cap and energy customers, which offset minor delays in new program transitions in the aerospace and defense market sector.
Non-GAAP EPS $2.14, which substantially exceeded guidance due to favorable discrete tax items. Non-GAAP EPS grew over 30% in fiscal 2025 compared to fiscal 2024.
Non-GAAP Operating Margin 5.8%, with a 40 basis point expansion compared to fiscal 2024. This was attributed to improved fixed cost leverage from higher revenue and continued productivity gains across manufacturing sites.
Free Cash Flow (Fiscal Fourth Quarter) $97 million, contributing to a fiscal 2025 total of $154 million. This exceeded projections and was achieved through reductions in borrowing and accelerated share repurchase activity.
Return on Invested Capital (ROIC) 14.6%, which was 570 basis points above the weighted average cost of capital. This improvement was driven by sustained working capital improvements and enhanced operating performance.
Cash Cycle 63 days, the best result in the past 5 years. This was achieved through a 10-day sequential improvement in inventory days and a year-over-year reduction in gross inventory of $82 million.
Aerospace and Defense Revenue Decreased 6% sequentially in the fiscal fourth quarter due to minor delays in new program ramps. Fiscal 2025 revenue for this sector was flat year-over-year, as new product launch delays and inventory adjustments offset double-digit growth in defense and space subsectors.
Healthcare/Life Sciences Revenue Increased 5% in fiscal 2025 year-over-year, driven by strength in the imaging and monitoring subsectors, new program ramp revenue, and customer demand increases for previously ramped products.
Industrial Sector Revenue Flat for fiscal 2025 year-over-year. Low double-digit growth in the semi-cap subsector offset reductions in industrial equipment and vehicle electrification.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Program Wins: Secured 28 new manufacturing programs worth $274 million annually in Q4. Fiscal 2025 saw 141 manufacturing wins, representing $941 million in annualized revenue.
Aerospace and Defense: Record wins in Aerospace and Defense, including unmanned aircraft and commercial aerospace programs.
Healthcare/Life Sciences: Wins included a therapeutics product remediation and an AI-powered digital cell analysis platform.
Industrial Sector: Strong wins of $165 million in Q4, including semi-cap programs and high-voltage product assembly for the rail industry.
Market Share Gains: Expanded relationships with commercial aerospace customers, healthcare, life sciences, and industrial sectors. Notable gains in semi-cap.
Revenue Growth: Revenue of $1.058 billion in Q4, marking the third consecutive quarter of sequential growth. Fiscal 2026 aims for 9%-12% revenue growth.
Operational Efficiency: Achieved a 40 basis point expansion in non-GAAP operating margin and reduced waste to landfill by over 30% globally.
Free Cash Flow: Generated $154 million in free cash flow for fiscal 2025, exceeding projections. Reduced debt by over $100 million.
Inventory Management: Reduced gross inventory by $82 million year-over-year and $330 million compared to fiscal 2023 year-end balance.
Sustainability Initiatives: Reduced Scope 1 and 2 emissions by over 10% and achieved zero waste to landfill status at 8 sites.
Investments: Investing in talent, technology, facilities, and advanced capabilities to support long-term growth and efficiency.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Conditions: Minor delays in new program transitions in the aerospace and defense market sector and muted near-term demand in the industrial sector could impact revenue growth.
Competitive Pressures: Challenges in maintaining market share and achieving growth targets in competitive sectors like semi cap and healthcare/life sciences.
Regulatory Hurdles: Anticipated increase in effective tax rates due to global minimum tax implementation in certain jurisdictions.
Supply Chain Disruptions: Inventory adjustments in the commercial aerospace supply chain and potential seasonality in the energy subsector.
Economic Uncertainties: Muted demand in industrial equipment and vehicle electrification subsectors, and seasonality affecting revenue in certain sectors.
Strategic Execution Risks: Ongoing investments in talent, technology, and facilities may strain resources and impact operational efficiency in the short term.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Growth: Plexus anticipates revenue growth in fiscal 2026 to exceed end market growth, with year-over-year growth expected in all market sectors. The company is targeting a 9% to 12% revenue growth goal.
Operating Margin: The company aims to achieve a 6% non-GAAP operating margin in fiscal 2026, with expectations to maintain or exceed this level as the year progresses.
Capital Expenditures: Capital spending for fiscal 2026 is projected to be in the range of $90 million to $110 million, consistent with fiscal 2025 spending.
Free Cash Flow: Plexus expects robust free cash flow of approximately $100 million for fiscal 2026, despite higher investments in working capital to support revenue growth.
Market Sector Performance: - Aerospace and Defense: Anticipates robust growth in fiscal 2026, driven by strong defense sector growth, new program ramps in unmanned aircraft, and a return to growth in commercial aerospace.
- Healthcare/Life Sciences: Expects robust growth supported by ongoing new program ramps and improved end market demand.
- Industrial Sector: Projects modest growth in fiscal 2026, with strength in semi cap and energy subsectors offsetting muted demand in other areas.
Investments: The company plans to continue investing in talent, technology, facilities, and advanced capabilities to support long-term competitiveness and operational efficiency.
Tax Rate: An effective tax rate of 16% to 18% is expected for fiscal 2026, influenced by the global minimum tax in certain jurisdictions.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Share Repurchase Activity: We have now generated $495 million of free cash flow over the past 2 fiscal years while deploying excess cash to reduce our borrowing and accelerate our share repurchase activity.
Expanded Share Repurchase Program: For fiscal 2025, we reduced our debt by over $100 million while continuing to return cash to shareholders through our expanded share repurchase program. For the fiscal fourth quarter, we acquired approximately 161,000 shares of our stock for $21.5 million. At the end of the fiscal year, we had approximately $85 million remaining on the current repurchase authorization.
Future Shareholder Value Creation: We plan to continue to deploy any excess cash to create additional shareholder value.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Is the company confident in its future growth trajectory?
A:Yes, the company is confident in its future growth trajectory, supported by investments such as the new Penang facility, which is expected to break even in one quarter and reach corporate profitability in two quarters. Growth is also driven by new program ramps and modest improvement in end markets.
Q:What are the company's opportunities in the AI space?
A:The company sees opportunities in power generation and thermal management within AI, as well as leveraging AI in healthcare and semi-cap businesses. They are not focusing on the compute market due to expected commoditization.
Q:Is the company anticipating any fallout in major market verticals from the government shutdown?
A:No, the company has not seen any indications of slowdown due to the government shutdown but is monitoring the situation closely.
Q:Has the company's view of semi-cap for fiscal 2026 changed?
A:No, the company views fiscal 2025 and 2026 as similar, with WFE growth in the low single digits. They expect significant share gains and similar growth in the low teens for semi-cap.
Q:What is driving growth in the energy sector?
A:Growth in the energy sector is driven by customer revenue growth in infrastructure, power generation, and electrification, as well as increased opportunities in EMEA.
Q:What is driving strength in the Healthcare/Life Sciences business?
A:Strength in the Healthcare/Life Sciences business is driven by new program ramps and the resolution of inventory overhang, along with modest market growth.
Q:What is the outlook for the Broadband Communications business?
A:The Broadband Communications business is expected to remain lumpy and nonlinear, with some strength in Q4 due to legacy product orders. The broader industrial recognition remains muted.
Q:How are customer conversations evolving regarding tariffs and visibility for fiscal 2026?
A:Customer conversations indicate stabilized markets with modest improvement. Tariffs remain a consideration for sourcing next-generation programs, but no significant movement of existing products is expected.
Q:Is the company focusing more on power generation and data centers?
A:Yes, the company is focusing more on power generation and data centers, with recent awards from substantial players in the space.
Q:What are the factors impacting the company's ability to meet or exceed operating margin targets in fiscal 2026?
A:Factors include revenue growth, higher incentive compensation, rapid ramp-up of facilities like Malaysia and Thailand, and productivity and automation efforts.
Q:Will the Malaysia facility reach full capacity quickly?
A:No, the Malaysia facility will not reach full capacity quickly but will operate efficiently at a fraction of its capacity while achieving corporate margins.
Q:What is the company's outlook for commercial aerospace?
A:The company expects some tailwind from commercial aerospace in fiscal 2026 but has not factored in any demand changes from Boeing or Airbus yet.
Q:What is the company's long-term ability to drive operating margin expansion?
A:The company expects to continue driving operating margin expansion through fixed cost leverage, automation efforts, and improved capacity utilization within existing sites.
Q:What is the company's strategy for engineering and sustaining services?
A:The company is optimistic about growing engineering and sustaining services, which are already above corporate target margins or have the potential to reach them as they scale.
Q:What caused the program ramp timing issue in Q4?
A:The program ramp timing issue in Q4 was caused by minor delays in the defense sector.
Q:What is the company's outlook for the defense sector?
A:The company expects strong growth in the defense sector in fiscal 2026, driven by new wins, expanded engagements, and investments in technology and cybersecurity.
Q:Review of Unclear Management Responses
A:Management avoided giving a direct answer regarding the timing of demand changes from Boeing or Airbus in the commercial aerospace sector, stating that it remains to be seen and lacks visibility.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Aerospace Defense
China
Defense sector
GE Vernova
Healthcare Life
Life Sciences
Sciences market
Sciences sector
Slide Plexus
Supplier
aircraft subsector
assembly
cap energy
change
customer demand
delay
delivery
demand cap
excess end
facility capability
funnel opportunity
imaging
industry
monitoring
non cash
organization
outlook sector
program transition
ramp Aerospace
ramp customer
ramp inclusive
sector digit
sector momentum
sector program
talent technology
technology facility
vision world
win Aerospace
win award
PLXS Transcript
Plexus Corp. (PLXS) Q2 2026 Earnings Call Transcript
Positive4-30
The earnings call indicates strong revenue growth, improved operational efficiency, and optimistic sector performance, particularly in aerospace and defense. The Q&A session further supports this with insights into efficient capital management and robust market demand. Despite some uncertainties in long-term margin targets, the overall sentiment is positive, especially with the company's strategic initiatives and growth outlook. The market cap suggests moderate volatility, aligning with a positive prediction.
Plexus Corp. (PLXS) Q1 2026 Earnings Call Transcript
Positive1-29
The earnings call highlights strong financial performance, with robust growth in key sectors and optimistic guidance. New program ramps and emerging market momentum in Aerospace and Defense, alongside automation and AI initiatives, enhance operational efficiency. Despite some uncertainties in component lead times and vague management responses, the overall sentiment is positive, supported by a high ROIC and effective cash cycle management. Given the market cap, the stock is expected to react positively, likely in the 2% to 8% range.
Plexus Corp. (PLXS) Q4 2025 Earnings Call Transcript
Unknown10-23
The earnings call shows a mixed picture. While there is confidence in growth, particularly in the Healthcare and Defense sectors, there are concerns over flat revenue in key areas like Industrial and Aerospace. The Q&A reveals uncertainty in the aerospace sector and reliance on future program ramps. Despite positive guidance and strategic investments, the flat revenue and minor delays temper expectations, leading to a neutral outlook.
Plexus Corp. (PLXS) Q3 2025 Earnings Call Transcript
Neutral7-24
PLXS Slides
PLXS Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
